nKPI – chronic condition management indicators

Since December 2022, of the 9 chronic condition management measures presented in Figure 31, 6 have improved and 3 showed no (or limited) change.

The data visualisation below (Figure 31) presents a selected measure, the change over time and a gauge showing the direction of the trend. For more information about these measures see the page for each indicator. Data tables supporting this visualisation are available at Data.

Figure 31: Trends(a) for selected chronic condition management indicators

PI07: Chronic conditions management plan type 2 diabetes – this measure has improved between December 2022 and June 2025.

PI23: Blood pressure recorded type 2 diabetes – this measure has improved between December 2022 and June 2025.

PI24: Blood pressure result of ≤140/90 mmHg type 2 diabetes – this measure has shown little or no change between December 2022 and June 2025.

PI05: HbA1c recorded (previous 6 months) type 2 diabetes – this measure has shown little or no change between December 2022 and June 2025.

PI06: HbA1c result of ≤53 mmol/mol type 2 diabetes – this measure has improved between December 2022 and June 2025.

PI18: Kidney function test type (both eGFR and ACR) type 2 diabetes – this measure has improved between December 2022 and June 2025.

PI19: Kidney function test result of ‘normal risk’ type 2 diabetes – this measure has improved between December 2022 and June 2025.

PI18: Kidney function test type (both eGFR and ACR) CVD – this measure has improved between December 2022 and June 2025.

PI19: Kidney function test result of ‘normal risk’ CVD – this measure has shown little or no change between December 2022 and June 2025.

PI07: Chronic conditions management plan type 2 diabetes – this measure has improved between December 2022 and June 2025.PI23: Blood pressure recorded type 2 diabetes – this measure has improved between December 2022 and June 2025.PI24: Blood pressure result of ≤140/90 mmHg type 2 diabetes – this measure has shown little or no change between December 2022 and June 2025.PI05: HbA1c recorded (previous 6 months) type 2 diabetes – this measure has shown little or no change between December 2022 and June 2025.PI06: HbA1c result of ≤53 mmol/mol type 2 diabetes – this measure has improved between December 2022 and June 2025.PI18: Kidney function test type (both eGFR and ACR) type 2 diabetes – this measure has improved between December 2022 and June 2025.PI19: Kidney function test result of ‘normal risk’ type 2 diabetes – this measure has improved between December 2022 and June 2025.PI18: Kidney function test type (both eGFR and ACR) CVD – this measure has improved between December 2022 and June 2025.PI19: Kidney function test result of ‘normal risk’ CVD – this measure has shown little or no change between December 2022 and June 2025.
  1. Trend is presented as a linear trend of proportions in comparable periods, including the June and December collection periods. The linear trend lines provide a general impression of the direction of the data. P-values were used to test the statistical significance of the trend. Indicators with no change either have high p-values and/or slopes near zero.

Notes

  1. Only data from December 2022 onwards are included in the trends presented (see Comparisons over time for more information). For trends for comparable periods before December 2022, see the visualisations on each indicator page. For data for all available periods see Data. For more information on changes to indicator specifications see Changes to indicators.
  2. Some of the indicators in the national Key Performance Indicators (nKPI) collection have, or can be split into, more than one part.
  3. For more information, including on interpreting changes over time, see Technical notes.

Source: nKPI data collection.

Previous page
Next page